TAK-500 is under clinical development by Takeda Pharmaceutical and currently in Phase II for Head And Neck Squamous Cell Carcinoma (HNSC). According to GlobalData, Phase II drugs for Head And Neck ...

Topamax tablets come in four strengths: 25 milligrams (mg), 50 mg, 100 mg, and 200 mg. Topamax sprinkle capsules come in two strengths: 15 mg and 25 mg. What are the typical dosages of Topamax?

TAK-500 is under clinical development by Takeda Pharmaceutical and currently in Phase II for Solid Tumor. According to GlobalData, Phase II drugs for Solid Tumor have a 38% phase transition success ...

Before you start trading, let's get a feel for what you'll be looking at: S&P 500: This giant represents ... stocks across various sectors. Nasdaq 100: This index is tech-heavy, concentrated ...

Joseph Schwartz, an analyst from Leerink Partners, reiterated the Buy rating on Ultragenyx Pharmaceutical (RARE – Research Report). The associated price target remains the same with $98.00.

Shares of this chipmaker have returned -9.9% over the past month versus the Zacks S&P 500 composite's -1.1% change. The Zacks Electronics - Semiconductors industry, to which Advanced Micro belongs ...

MG Motor India on Wednesday said the company is set to establish 100 new touchpoints by the end of this year in tier-3 and -4 cities and rural market across India, with a goal of enhancing ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Advanced Micro Devices and Intel experienced ... news could trigger a broader sell-off in the near term. E-mini Nasdaq-100 Index futures are lower late Friday after giving up earlier gains.

Siete, an Inc. 2023 Best Workplaces honoree, expects to hit $500 million in annual sales in 2024 and sells its products at 37,000 stores, including Target, Walmart, and many grocery stores.